Literature DB >> 13902249

[Antistreptokinase and streptokinase resistance].

R GROSS, W HARTL.   

Abstract

Keywords:  FIBRINOLYSIN/therapy; STREPTODORNASE AND STREPTOKINASE/antagonist

Mesh:

Substances:

Year:  1962        PMID: 13902249     DOI: 10.1007/bf01492707

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  14 in total

1.  [On the dosage of streptokinase in fibrinolytic therapy].

Authors:  A STACHER; J BOEHNEL
Journal:  Wien Klin Wochenschr       Date:  1961-09-29       Impact factor: 1.704

2.  [The antistreptokinase reaction in the field of serodiagnosis of rheumatic diseases].

Authors:  W HARTL
Journal:  Z Rheumaforsch       Date:  1962-04

3.  [Medically induced fibrinolysis].

Authors:  E DEUTSCH; P ELSNER; M FISCHER
Journal:  Wien Z Inn Med       Date:  1960-12

4.  [Thrombolysis by infusions of highly purified streptokinase. Experience and research on the first 50 patients].

Authors:  R GROSS; W HARTL; G KLOSS; B RAHN
Journal:  Dtsch Med Wochenschr       Date:  1960-12-02       Impact factor: 0.628

5.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

6.  Inhibition of clotting as the result of plasminogen activation by streptokinase. 1. Studies of the inactivation of fibrinogen.

Authors:  P GLAS; F K BELLER
Journal:  Thromb Diath Haemorrh       Date:  1960-06-15

7.  The intravascular use of streptokinase.

Authors:  A J JOHNSON; A P FLETCHER; W R McCARTY; W S TILLETT
Journal:  Ann N Y Acad Sci       Date:  1957-08-30       Impact factor: 5.691

8.  [Autoactivation and autofibrinolysis; a simple rapid method for obtaining highly active human fibrinolytic material].

Authors:  K N VON KAULLA
Journal:  Klin Wochenschr       Date:  1957-07-01

9.  METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.

Authors:  L R Christensen
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

10.  Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

View more
  5 in total

1.  Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

Authors:  K A Davies; P Mathieson; C G Winearls; A J Rees; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

2.  [Changes of blood coagulation factors in long-term treatment with anticoagulants and in liver cirrhosis].

Authors:  L Nowicki; K W Schneider; M Reimers
Journal:  Blut       Date:  1966-04

3.  The effect of antigen given intravenously on specific antigen-sensitive lymphocytes of peripheral blood in man.

Authors:  H W Kreth; G Thiessen; H Deicher
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

4.  [Behavior of certain coagulation tests during therapy with streptokinase].

Authors:  K W Schneider; L Nowicki
Journal:  Blut       Date:  1966-02

5.  [Results of various methods of separation of specific and unspecific antistreptolysin O titer in human serum].

Authors:  J Knolle
Journal:  Klin Wochenschr       Date:  1966-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.